Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;98(8):e14453.
doi: 10.1097/MD.0000000000014453.

Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis

Affiliations
Review

Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis

Jianzhen Pan et al. Medicine (Baltimore). 2019 Feb.

Abstract

Objective: Compelling evidence has shown that aggressive resuscitation bundles are one of the cornerstones of the successful treatment of patients with sepsis. Recent studies suggest that lactate normalization during resuscitation is a more powerful indicator of resuscitative adequacy; however, early lactate clearance-guided therapy is still not recommended. We performed this meta-analysis to evaluate the effect of early lactate clearance-directed therapy as a potentially more effective resuscitation target.

Methods: Studies were identified using PubMed, Embase, and the Cochrane Library without region, publication type, or language restrictions. Randomized trials were included when they compared the efficacy and safety of lactate clearance-guided resuscitation versus central venous oxygen saturation (ScvO2)-guided therapy. The primary outcome was mortality, and the secondary outcomes were intensive care unit (ICU) stay, length of hospital stay, mechanical ventilation time, Acute Physiology and Chronic Health Evaluation-II (APACHE-II) score, and Sepsis-related Organ Failure Assessment (SOFA) score.

Results: Seven randomized controlled trials encompassing 1301 cases were reviewed. Compared with guided ScvO2 therapy, early lactate clearance-directed therapy was associated with decreased in-hospital mortality (relative ratio [RR] 0.68, 95% confidence interval [CI] 0.56 to 0.82), shorter ICU stay (mean difference [MD] -1.64 days, 95% CI -3.23 to -0.05), shorter mechanical ventilation time (MD -10.22 hours, 95% CI -15.94 to -4.5), and lower APACHE-II scores (MD -4.47, 95% CI -7.25 to -1.69). However, patients undergoing early lactate clearance-guided therapy had similar lengths of hospital stay and similar SOFA scores.

Conclusions: As a specific indicator of resuscitation outcome, lactate clearance alone is superior to ScvO2 alone during a standard resuscitation paradigm. The optimal or desired rate of lactate clearance is still a contentious area. To guide resuscitation and normalize lactate levels in patients, repeating lactate measurements every 2 hours until the patient has met a lactate clearance of 10% or greater may be helpful.

Trial registration number: PROSPERO CRD42018100515.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interests.

Figures

Figure 1
Figure 1
Flow diagram of study inclusion. RCT = randomized controlled trial.
Figure 2
Figure 2
Effect of lactate clearance-guided therapy on in-hospital mortality compared with ScvO2-guided therapy. CI = confidence interval, M-H = Mantel-Haenszel.
Figure 3
Figure 3
Effect of lactate clearance-guided therapy on hospital length of stay (A) and intensive care unit length of stay (B) compared with early goal-directed therapy. CI = confidence interval, SD = standard deviation.
Figure 4
Figure 4
Effect of lactate clearance-guided therapy on mechanical ventilation (A), Sepsis-related Organ Failure Assessment score (B), Acute Physiology and Chronic Health Evaluation-II (C) compared with early goal-directed therapy. CI = confidence interval, SD = standard deviation.
Figure 5
Figure 5
Publication bias of in-hospital mortality. RR = relative ratio
Figure 6
Figure 6
Trial sequential analysis. ScvO2 = central venous oxygen saturation, TSA = trial sequential analysis

Similar articles

Cited by

References

    1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801–10. - PMC - PubMed
    1. Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014;312:90–2. - PubMed
    1. Rhee C, Murphy MV, Li L, et al. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis 2015;60:88–95. - PMC - PubMed
    1. Bone R, Balk R, Cerra F. American College of Chest PhysiciansSociety of Critical Care Medicine Consensus Conference definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–74. - PubMed
    1. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6. - PubMed